代谢功能障碍相关脂肪性肝病和/或酒精摄入的肝癌风险:一项全国性研究
该研究基于韩国2009至2010年全国健康体检的40-79岁人群,按非MASLD、MASLD、MetALD和ALD分类,随访中位13.3年。与非MASLD相比,肝细胞癌风险从MASLD、MetALD到ALD呈阶梯式升高。在老年、女性和肝硬化亚组中,MetALD的肝细胞癌风险与ALD相似。
要点
- 与非MASLD相比,肝细胞癌风险从MASLD、MetALD到ALD呈阶梯式升高。
- 老年和非肝硬化亚组更易受MASLD和/或酒精摄入对肝细胞癌风险的不利影响。
- 在老年、女性和肝硬化亚组中,MetALD的肝细胞癌风险与ALD相似。
核心结论
- 与非MASLD相比,肝细胞癌风险从MASLD、MetALD到ALD呈阶梯式升高。
- 为有效一级预防肝细胞癌,需采取综合措施改善代谢功能障碍和酒精摄入习惯。
研究设计与样本
- 纳入2009至2010年韩国全国健康体检的40-79岁参与者,共6,412,209人。
- 按非MASLD、MASLD、MetALD和ALD分类,主要结局为肝细胞癌发生率,采用多变量Cox比例风险模型估计风险。
主要发现
- 非MASLD、MASLD、MetALD和ALD的比例分别为59.5%、32.4%、4.8%和3.4%。
- 中位随访13.3年期间,27,118人新发肝细胞癌。
- 与非MASLD相比,MASLD的aHR为1.66(95%CI 1.62-1.71),MetALD的aHR为2.17(95%CI 2.08-2.27),ALD的aHR为2.34(95%CI 2.24-2.45)。
- 老年和非肝硬化亚组更易受MASLD和/或酒精摄入对肝细胞癌风险的不利影响。
- 在老年、女性和肝硬化亚组中,MetALD的肝细胞癌风险与ALD相似。
关键数值与推荐
- MetALD定义为每周酒精摄入男性210-420 g、女性140-350 g。
- ALD定义为过量酒精摄入,每周酒精男性≥420 g或女性≥350 g。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: New terminologies of metabolic dysfunction-associated steatotic liver disease (MASLD) have been developed. We assessed hepatocellular carcinoma (HCC) risk across MASLD and/or alcohol intake. METHODS: We included participants aged 40-79 years receiving a national health checkup from 2009 to 2010 in the Republic of Korea, classified as follows: non-MASLD, MASLD, MASLD with increased alcohol intake (MetALD; weekly alcohol 210-420 g for male and 140-350 g for female individuals), and alcohol-associated liver disease (ALD; excessive alcohol intake with weekly alcohol ≥420 g for male or ≥350 g for female individuals). The primary outcome was HCC incidence. HCC risk was estimated using multivariable Cox proportional hazard models. RESULTS: Among 6,412,209 participants, proportions of non-MASLD, MASLD, MetALD, and ALD cases were 59.5%, 32.4%, 4.8%, and 3.4%, respectively. During follow-up (median 13.3 years), 27,118 had newly developed HCC. Compared with non-MASLD, the HCC risk increased from MASLD (adjusted hazard ratio [aHR] 1.66, 95% confidence interval [CI] 1.62-1.71) and MetALD (aHR 2.17, 95% CI 2.08-2.27) to ALD (aHR 2.34, 95% CI 2.24-2.45) in a stepwise manner. Furthermore, the older and non-cirrhosis subgroups were more vulnerable to detrimental effects of MASLD and/or alcohol intake, concerning HCC risk. Among the older, female, and cirrhosis subgroups, MetALD poses similar HCC risks as ALD. DISCUSSION: HCC risk increased from MASLD and MetALD to ALD in a stepwise manner, compared with non-MASLD. For an effective primary prevention of HCC, a comprehensive approach should be required to modify both metabolic dysfunction and alcohol intake habit.
引用
- Yun B, Park H, Ahn SH, et al. Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study. Am J Gastroenterol. 2024. PMID: 38934496. doi:10.14309/ajg.0000000000002920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。